Looking to publish in European Journal of Cancer? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowThe European Journal of Cancer (EJC) integrates preclinical, digital, translational, and clinical research in cancer, from epidemiology, carcinogenesis and biology through to innovations in cancer treatment and patient care. It publishes original research, reviews, previews, editorial comments and correspondence and is the official journal of the European Organisation for Research and Treatment of Cancer (EORTC) and the European Society of Breast Cancer Specialists (EUSOMA).
Looking to publish in European Journal of Cancer? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
European Journal of Cancer accepts the following article types. Click on an article type to view submission instructions.
Original Research
Review Articles
Correspondence
Current Perspectives
Editorials
Recent Publications
Corrigendum to ‘Performance of FIT-based colorectal cancer screening in Denmark from 2014 to 2022’ [Eur J Cancer 241 (June)(2026) 116788]
Tina Bech Olesen, Signe Bülow Therkildsen, Petra Hall Viborg, Nina Brander, Lennart Friis-Hansen, Mette Høyrup, Henry Jensen, Sanne Kjær-Frifeldt, Lasse Pedersen, Mikkel Sjöström, Bo Søndergaard, Morten Rasmussen, Berit Andersen
No Prognostic Role for FIGO grading in Mismatch Repair Deficient Endometrial Carcinoma
Famke C. Wakkerman, Cathalijne C.B. Post, Gitte Ørtoft, Estrid Høgdall, Jan J. Jobsen, Rubina Razack, Cor D. de Kroon, Remi A. Nout, Dorine S.J. Tseng, Nienke Kuijsters, Marie A.D. Haverkort, Melanie E. Powell, Alexandra Leary, Linda R. Mileshkin, Pearly Khaw, Lois E. Shepherd, Stephanie M. de Boer, Judith R. Kroep, Vincent T.H.B.M. Smit, Carien L. Creutzberg, Nanda Horeweg, Tjalling Bosse
Outcomes of CAR T-Cell Therapy in Transformed Indolent Non-Hodgkin Lymphomas and de novo DLBCL: a comparative analysis from the Italian CAR T-SIE study
Nicole Fabbri, Beatrice Casadei, Annalisa Chiappella, Federico Stella, Livia Donzelli, Eugenio Galli, Marcello Riva, Massimo Martino, Anna Maria Barbui, Maurizio Musso, Mirko Farina, Piera Angelillo, Ilaria Cutini, Armando Santoro, Federica Cavallo, Paolo Rivela, Alessia Castellino, Mauro Krampera, Giuseppe Petruzzellis, Giovanni Grillo, Lisa Argnani, Francesca Bonifazi, Paolo Corradini, Pier Luigi Zinzani
Occupational solar UV-exposure and risk of cutaneous melanoma among Danish workers: A nationwide cohort study
Ida Kristensen, Sigrun Alba Johannesdottir Schmidt, Alexander Wilhelm Gorny, Inge Brosbøl Iversen, Morten Fenger-Grøn, Else Toft Würtz, Michelle C Turner, Kasper Grandahl, Henrik Albert Kolstad, Zara Ann Stokholm
Chemotherapy duration and patient-reported outcomes in HER2-positive early breast cancer: results from the TRAIN-3 study
Fleur M Louis, Anna van der Voort, Mees D Egeler, Mette S van Ramshorst, Ingrid AM Mandjes, Inge Kemper, Mariette J Agterof, Wim A van der Steeg, Joan B Heijns, Marlies L van Bekkum, Ester JM Siemerink, Philomeen M Kuijer, Astrid Scholten, Jelle Wesseling, Marie-Jeanne TFD Vrancken Peeters, Ritse M Mann, Lonneke V van de Poll-Franse, Gabe S Sonke
Frequently asked questions
How long does it take to publish?
Proof corrections are requested within two days after proofs are sent. Manuscripts chosen for SSRN preprint posting are made publicly available as soon as they pass the initial desk review.
Reformat to European Journal of Cancer using Livewrite PremiumIs a cover letter required?
A covering letter should identify the person responsible for editorial correspondence, including address, telephone number and email address.
Reformat to European Journal of Cancer using Livewrite PremiumWhat are the publication costs?
Article publishing charge (APC) applies for open access articles if the manuscript is accepted.
Reformat to European Journal of Cancer using Livewrite Premium